Kayser, S., Schlenk, R. F., Krämer, A., Müller-Tidow, C., & Bornhäuser, M. (2021). Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: An international collaborative study. Haematologica, 106(12), . https://doi.org/10.3324/haematol.2021.278722
Chicago Style (17th ed.) CitationKayser, Sabine, Richard Friedrich Schlenk, Alwin Krämer, Carsten Müller-Tidow, and Martin Bornhäuser. "Characteristics and Outcome of Patients with Low-/intermediate-risk Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: An International Collaborative Study." Haematologica 106, no. 12 (2021). https://doi.org/10.3324/haematol.2021.278722.
MLA (9th ed.) CitationKayser, Sabine, et al. "Characteristics and Outcome of Patients with Low-/intermediate-risk Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: An International Collaborative Study." Haematologica, vol. 106, no. 12, 2021, https://doi.org/10.3324/haematol.2021.278722.